1-5 of 5
Kevin W. Harris
Close
Sort by
Journal Articles

Distinct classes of c-Kit–activating mutations differ in their ability to promote RUNX1-ETO–associated acute myeloid leukemia

Heidi J. Nick, Hyung-Gyoon Kim, Chia-Wei Chang, Kevin W. Harris, Vishnu Reddy, Christopher A. Klug
Journal: Blood
Blood (2012) 119 (6): 1522–1531.
https://doi.org/10.1182/blood-2011-02-338228
Published: 2012
Includes: Supplemental data
Journal Articles

Inhibition of Cytokine Receptor gp130 Signaling in Breast Cancer Cells Markedly Suppresses Secretion of Tissue Factor-Expressing Tumor Microparticles.

Diego A. de Idiaquez, MD, Dannielle E. Branam, Larry Lamb, PhD, Dongquan Chen, PhD, Lihong Teng, PhD, MD, Katri S. Selander, MD, PhD, Kevin W. Harris, MD, PhD
Journal: Blood
Blood (2005) 106 (11): 1935.
https://doi.org/10.1182/blood.V106.11.1935.1935
Published: 2005
Journal Articles

Purification and characterization of the yeast-expressed erythropoietin mutant Epo (R103A), a specific inhibitor of human primary hematopoietic cell erythropoiesis

Suzanne Burns, Murat O. Arcasoy, Li Li, Elizabeth Kurian, Katri Selander, Peter D. Emanuel, Kevin W. Harris
Journal: Blood
Blood (2002) 99 (12): 4400–4405.
https://doi.org/10.1182/blood.V99.12.4400
Published: 2002
Journal Articles

The Distal Cytoplasmic Domain of the Erythropoietin Receptor Induces Granulocytic Differentiation in 32D Cells

Kevin W. Harris, Xian-Jue Hu, Suzanne Schultz, Murat O. Arcasoy, Bernard G. Forget, Nanette Clare
Journal: Blood
Blood (1998) 92 (4): 1219–1224.
https://doi.org/10.1182/blood.V92.4.1219
Published: 1998
Journal Articles

Familial Erythrocytosis Associated With a Short Deletion in the Erythropoietin Receptor Gene

Murat O. Arcasoy, Barbara A. Degar, Kevin W. Harris, Bernard G. Forget
Journal: Blood
Blood (1997) 89 (12): 4628–4635.
https://doi.org/10.1182/blood.V89.12.4628
Published: 1997